Biomet’s owners have selected Bank of America Merrill Lynch, Goldman Sachs Group and JPMorgan Chase to lead the IPO.
The company was taken private in 2007 for $11.3 billion by Blackstone Group, DDR & Co., TPG and Goldman Sachs Group.
The offering could come in the first half of 2014 and raise more than $1 billion, according to the report.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
